APO Research, Inc.

Find your market.

Compare the product scope, applications and research editions relevant to your next decision.

Our research approach
Browse the complete product directory →

9,053 topics, 45,265 reports

Clear all filters

Pharma & Healthcare

Antibody-drug Conjugates

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.

Types
Adcetris · Kadcyla
Applications
Breast Cancer · Lymphoma

5 editions22 December 2025

View 5 research editions
$4,250Single user · USD · Market Outlook & Growth OpportunitiesExplore product: Antibody-drug ConjugatesCompare research options for Antibody-drug Conjugates
APO Research, Inc.